Search Within

Leonard B Saltz

  1. "2009"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (9)
  3. Book Section (1)
Groups
  1. Department of Medicine (27)
  2. Gastrointestinal Oncology Service (27)
  3. Solid Tumor Oncology Division (27)
  4. Surgery (5)
  5. Center for Pancreatic Cancer Research (4)
  6. Colorectal Surgery (4)

More Groups

People
  1. Nancy Kemeny (4)
  2. David Kelsen (3)
  3. Martin Weiser (3)
  4. Philip Paty (3)
  5. Anne Covey (2)
  6. Constantinos Sofocleous (2)

More People

Years
  1. 2009 (27)
Publications
  1. Journal of Clinical Oncology (10)
  2. Clinical Cancer Research (2)
  3. Journal of the National Comprehensive Cancer Network (2)
  4. Nature Reviews Clinical Oncology (2)
  5. American Journal of Hematology/Oncology (1)
  6. Annals of Thoracic Surgery (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. American Association for Cancer Research (3)
  3. Nature Publishing Group (3)
  4. Elsevier Science, Inc. (2)
  5. Harborside Press (2)
  6. Annual Reviews (1)

More Publishers

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation and treatment of colorectal cancer
    Book Section

    Saltz, L. B.; Duffy, A. G.
    In Stubblefield, M. D.; O'Dell, M. W. (Eds.) Cancer Rehabilitation: Principles and Practice. 1st ed (2009)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab in combination with cetuximab plus irinotecan in irinotecan-refractory colorectal cancer (CRC) patients who have progressed on a bevacizumab-containing regimen (The BOND 2.5 Study)
    Meeting Abstract

    Segal, N. H.; Reidy-Lagunes, D.; Capanu, M.; Kemeny, N.; Chung, K.; Kelsen, D.; Hollywood, E.; Goodman-Davis, N.; Saltz, L. B.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Safety and efficacy of AMG 655 plus modified FOLFOX6 (mFOLFOX6) and bevacizumab (B) for the first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Saltz, L.; Infante, J.; Schwartzberg, L.; Stephenson, J.; Rocha-Lima, C.; Galimi, F.; Dillingham, K.; Hsu, M.; Wiezorek, J.; Fuchs, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Use of two-year disease-free survival (DFS) as a primary endpoint in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: New data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, NSAPB C-06 and C-07, and C89803
    Meeting Abstract

    Sargent, D. J.; Yothers, G.; Van Cutsem, E.; Cassidy, J.; Saltz, L.; Wolmark, N.; Shi, Q.; Buyse, M.; de Gramont, A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Impact of older age on the efficacy of newer adjuvant therapies in > 12,500 patients (pts) with stage II/III colon cancer: Findings from the ACCENT Database
    Meeting Abstract

    McCleary, N. A. J.; Meyerhardt, J.; Green, E.; Yothers, G.; de Gramont, A.; Van Cutsem, E.; O'Connell, M.; Twelves, C.; Saltz, L.; Sargent, D.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Adjuvant therapy report card: Patients with stage II/III colon cancer grade their oncologists
    Meeting Abstract

    Love, N.; Ziel, K. A.; Bylund, C.; Elder, M.; Ellis, L. M.; Grothey, A.; Meropol, N. J.; Paley, D.; Ravdin, P. M.; Saltz, L. B.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • KRAS mutation, cancer recurrence, and patient survival in stage III colon cancer: Findings from CALGB 89803
    Meeting Abstract

    Fuchs, C.; Ogino, S.; Meyerhardt, J. A.; Irahara, N.; Niedzwiecki, D.; Hollis, D.; Saltz, L. B.; Mayer, R. J.; Bertagnolli, M. M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment
    Meeting Abstract

    Poultsides, G. A.; Servais, E. L.; Saltz, L. B.; Patil, S.; Kemeny, N. E.; Guillem, J. G.; Weiser, M.; Temple, L. K.; Wong, W.; Paty, P. B.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Identification and biological characterization of exon 4 KRAS mutations by MALDI-TOF Mass Spectrometry based genotyping
    Meeting Abstract

    Janakiraman, M.; Zeng, Z.; Chitale, D.; Halilovic, E.; Rosen, N.; Vakiani, E.; Heguy, A.; Ladanyi, M.; Jhanwar, S.; Saltz, L.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • BRAF V600E mutation analysis in metastatic colorectal carcinoma: MSKCC experience
    Meeting Abstract

    Nafa, K.; Arcila, M. E.; Saltz, L. B.; Ladanyi, M.
    Journal of Molecular Diagnostics (2009)

    Fulltext@MSK | Save